Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulation
Active TBS-DLPFC for Depression
N/A
Waitlist Available
Led By Rajamannar Ramasubbu, MD,FRCPC,MSc
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 5 days of tbs treatment
Awards & highlights
Summary
This study investigates the brain-based biomarkers of treatment response to accelerated theta burst stimulation (aTBS) in patients with Major Depressive Disorder resistant to pharmacological treatment(MDD) in an open label design.
Eligible Conditions
- Depression
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at 5 days of tbs treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 5 days of tbs treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hamilton Depression Rating Scale
Secondary study objectives
1. Montgomery-Åsberg Depression Rating Scale (MADRS)
2. Columbia Suicide Severity Rating Scale ( CSSRS)
2. Hamilton Anxiety rating Scale (HAM-A)
+7 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Active TBS-DLPFCExperimental Treatment1 Intervention
There is only one arm. All participants will receive Theta Burst Stimulation (transcranial magnetic stimulation) of the dorsolateral prefrontal cortex.
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
805 Previous Clinical Trials
884,002 Total Patients Enrolled
31 Trials studying Depression
10,610 Patients Enrolled for Depression
Rajamannar Ramasubbu, MD,FRCPC,MScPrincipal InvestigatorUniversity of Calgary, Department of Psychiatry
Share this study with friends
Copy Link
Messenger